Search Reports

	Industry Analysis
	Company Reports
	Industry Blogs
	Press Coverages

All Research Reports

- Healthcare Industry

- Opportunities in Ind...

- Insulin Delivery Sys...

- Emerging Pharmaceuti...

- Global Protein Thera...

Latest Industry Reports

Request a Quote

Global In Vitro Diagnostic Market Analysis

Publish Date: May, 2008

No. of Pages: 100

Delivery: PDF Format (Single User License) - Up to 24 hours Delivery

Global In Vitro Diagnostic Market Analysis

	Electronic Access - Single User PDF		US$ 1600.00
	CD-ROM Mail Delivery		US$ 1800.00
	Hard Copy Mail Delivery		US$ 1800.00
	Electronic Access - Multi-User License		US$ 2000.00

Description	Table of Content	List of Figures & Tables

1. Analyst View

2. In Vitro Diagnostic Market Overview
     2.1 Introduction
     2.2 What is In Vitro Diagnostics?
     2.3 Market Size & Growth
     2.4 Market Share of Top Players

3. Market Drivers
     3.1 Chronic & Infectious Diseases
     3.2 New Technologies
     3.3 Emerging Markets
     3.4 Diversifying Applications
     3.5 Healthcare Infrastructure

4. Clinical Segmentation (Current & Future Scenario - 2012)
     4.1 Point of Care Diagnostics
     4.2 Clinical Chemistry
     4.3 Immunochemistry
     4.4 Hematology
     4.5 Molecular Diagnostics
     4.6 Microbiology
     4.7 Coagulation
     4.8 Pathology
     4.9 Blood Screen Immunoassays
     4.10 Immunohematology

5. Segmentation by Indication (Current & Future Scenario - 2012)
     5.1 Diabetes
     5.2 Cardiovascular
     5.3 Cancer
     5.4 HIV
     5.5 Tuberculosis

6. Geographical Segmentation (Current & Future Scenario - 2012)
     6.1 North America
            6.1.1 United States
            6.1.2 Canada
     6.2 Europe
            6.2.1 Germany
            6.2.2 France
            6.2.3 Italy
            6.2.4 United Kingdom
            6.2.5 Spain
            6.2.6 Other European Countries
     6.3 Japan
     6.4 Rest of the World
            6.4.1 China
            6.4.2 South Korea
            6.4.3 India
            6.4.4 Turkey
            6.4.5 Brazil
            6.4.6 Mexico

7. Roadblocks
     7.1 Regulatory & Reimbursement Issues
     7.2 R&D & Short Product Lifecycle
     7.3 Awareness

8. Key Player Profiles
     8.1 Roche Holding Ltd.
     8.2 Abbott Laboratories
     8.3 Siemens AG
     8.4 Beckman Coulter, Inc.
     8.5 Ortho-Clinical Diagnostics